Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency.

PubWeight™: 2.58‹?› | Rank: Top 1%

🔗 View Article (PMC 189034)

Published in J Virol on May 01, 1995

Authors

S Debrus1, C Sadzot-Delvaux, A F Nikkels, J Piette, B Rentier

Author Affiliations

1: Laboratory of Fundamental Virology, Institute of Pathology, University of Liège, Belgium.

Articles citing this

Varicella-zoster virus. Clin Microbiol Rev (1996) 3.03

Multifocal VZV vasculopathy with temporal artery infection mimics giant cell arteritis. Neurology (2013) 2.94

Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons. Proc Natl Acad Sci U S A (1996) 2.71

Varicella zoster virus vasculopathy: analysis of virus-infected arteries. Neurology (2011) 2.71

Aberrant intracellular localization of Varicella-Zoster virus regulatory proteins during latency. Proc Natl Acad Sci U S A (1998) 2.65

Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA. J Virol (1996) 2.41

Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking. J Virol (1997) 2.34

Varicella-zoster virus gene expression in latently infected and explanted human ganglia. J Virol (2000) 2.23

Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency. Neurol Clin (2008) 1.99

Reactivated and latent varicella-zoster virus in human dorsal root ganglia. Proc Natl Acad Sci U S A (1995) 1.68

Essential role played by the C-terminal domain of glycoprotein I in envelopment of varicella-zoster virus in the trans-Golgi network: interactions of glycoproteins with tegument. J Virol (2001) 1.55

Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons. J Virol (2006) 1.54

Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus. J Virol (2001) 1.53

Varicella-zoster virus vasculopathy: immune characteristics of virus-infected arteries. Neurology (2012) 1.52

Virus-encoded homologs of cellular interleukin-10 and their control of host immune function. J Virol (2009) 1.49

Varicella-zoster virus-infected human sensory neurons are resistant to apoptosis, yet human foreskin fibroblasts are susceptible: evidence for a cell-type-specific apoptotic response. J Virol (2003) 1.46

Review: The neurobiology of varicella zoster virus infection. Neuropathol Appl Neurobiol (2011) 1.45

The immediate-early 63 protein of Varicella-Zoster virus: analysis of functional domains required for replication in vitro and for T-cell and skin tropism in the SCIDhu model in vivo. J Virol (2004) 1.40

The replication cycle of varicella-zoster virus: analysis of the kinetics of viral protein expression, genome synthesis, and virion assembly at the single-cell level. J Virol (2009) 1.38

Varicella-zoster virus ORF47 protein serine kinase: characterization of a cloned, biologically active phosphotransferase and two viral substrates, ORF62 and ORF63. J Virol (2001) 1.37

Characterization of varicella-zoster virus gene 21 and 29 proteins in infected cells. J Virol (2002) 1.24

The varicella-zoster virus open reading frame 63 latency-associated protein is critical for establishment of latency. J Virol (2004) 1.22

Immunomodulatory properties of a viral homolog of human interleukin-10 expressed by human cytomegalovirus during the latent phase of infection. J Virol (2008) 1.22

Varicella-Zoster virus IE63, a major viral latency protein, is required to inhibit the alpha interferon-induced antiviral response. J Virol (2007) 1.18

Phosphorylation and nuclear localization of the varicella-zoster virus gene 63 protein. J Virol (1996) 1.14

Configuration of latent varicella-zoster virus DNA. J Virol (1995) 1.12

Simian varicella virus pathogenesis. Curr Top Microbiol Immunol (2010) 1.08

Varicella-zoster virus open reading frame 4 encodes an immediate-early protein with posttranscriptional regulatory properties. J Virol (1997) 1.07

Varicella-zoster virus infection of human neural cells in vivo. Proc Natl Acad Sci U S A (2004) 1.06

Varicella-zoster virus immediate-early 63 protein interacts with human antisilencing function 1 protein and alters its ability to bind histones h3.1 and h3.3. J Virol (2008) 1.06

Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for replication in vitro are also critical for efficient establishment of latency. J Virol (2005) 1.05

Nuclear import of the varicella-zoster virus latency-associated protein ORF63 in primary neurons requires expression of the lytic protein ORF61 and occurs in a proteasome-dependent manner. J Virol (2008) 0.97

Varicella-zoster virus ORF47 protein kinase, which is required for replication in human T cells, and ORF66 protein kinase, which is expressed during latency, are dispensable for establishment of latency. J Virol (2003) 0.96

Development of recombinant varicella-zoster viruses expressing luciferase fusion proteins for live in vivo imaging in human skin and dorsal root ganglia xenografts. J Virol Methods (2008) 0.95

Varicella-zoster virus gene 21: transcriptional start site and promoter region. J Virol (1998) 0.93

A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation. J Gen Virol (2015) 0.93

Mutational analysis of the varicella-zoster virus ORF62/63 intergenic region. J Virol (2006) 0.91

Localization of varicella-zoster virus gene 21 protein in virus-infected cells in culture. J Virol (1998) 0.88

Search for varicella zoster virus and herpes simplex virus-1 in normal human cerebral arteries. J Neurovirol (2013) 0.88

Phosphorylation of the nuclear form of varicella-zoster virus immediate-early protein 63 by casein kinase II at serine 186. J Virol (2009) 0.88

Distribution of varicella zoster virus and herpes simplex virus in disseminated fatal infections. J Clin Pathol (1996) 0.87

Varicella-zoster virus IE4 protein interacts with SR proteins and exports mRNAs through the TAP/NXF1 pathway. PLoS One (2009) 0.86

Downregulation of varicella-zoster virus (VZV) immediate-early ORF62 transcription by VZV ORF63 correlates with virus replication in vitro and with latency. J Virol (2006) 0.86

A simian varicella virus (SVV) homolog to varicella-zoster virus gene 21 is expressed in monkey ganglia latently infected with SVV. J Virol (1996) 0.85

Rodent models of varicella-zoster virus neurotropism. Curr Top Microbiol Immunol (2010) 0.84

Clinical and molecular aspects of varicella zoster virus infection. Future Neurol (2009) 0.84

The varicella-zoster virus immediate-early 63 protein affects chromatin-controlled gene transcription in a cell-type dependent manner. BMC Mol Biol (2007) 0.83

Identification of phosphorylated residues on varicella-zoster virus immediate-early protein ORF63. J Gen Virol (2010) 0.83

An in vitro model of latency and reactivation of varicella zoster virus in human stem cell-derived neurons. PLoS Pathog (2015) 0.81

Recombinant monoclonal antibody recognizes a unique epitope on varicella-zoster virus immediate-early 63 protein. J Virol (2012) 0.81

The IE180 protein of pseudorabies virus suppresses phosphorylation of translation initiation factor eIF2α. J Virol (2012) 0.81

Human trigeminal ganglionic explants as a model to study alphaherpesvirus reactivation. J Neurovirol (2012) 0.80

Construction of recombinant mouse IgG1 antibody directed against varicella zoster virus immediate early protein 63. Hybridoma (Larchmt) (2008) 0.79

Two alphaherpesvirus latency-associated gene products influence calcitonin gene-related peptide levels in rat trigeminal neurons. Neurobiol Dis (2006) 0.76

Articles cited by this

Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene (1988) 52.71

Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J Virol (1974) 26.25

The complete DNA sequence of varicella-zoster virus. J Gen Virol (1986) 16.00

Identification of herpes simplex virus DNA sequences which encode a trans-acting polypeptide responsible for stimulation of immediate early transcription. J Mol Biol (1984) 8.87

A generalized technique for deletion of specific genes in large genomes: alpha gene 22 of herpes simplex virus 1 is not essential for growth. Cell (1981) 8.56

Characterization of the herpes simplex virion-associated factor responsible for the induction of alpha genes. J Virol (1983) 8.31

Herpes simplex virus 1 mutant deleted in the alpha 22 gene: growth and gene expression in permissive and restrictive cells and establishment of latency in mice. J Virol (1985) 4.17

Processing of the herpes simplex virus regulatory protein alpha 22 mediated by the UL13 protein kinase determines the accumulation of a subset of alpha and gamma mRNAs and proteins in infected cells. Proc Natl Acad Sci U S A (1993) 3.77

Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses. Proc Natl Acad Sci U S A (1988) 3.49

The herpes simplex virus type 1 alpha protein ICP27 can act as a trans-repressor or a trans-activator in combination with ICP4 and ICP0. J Virol (1988) 3.33

The varicella-zoster virus immediate-early protein IE62 is a major component of virus particles. J Virol (1992) 2.80

Varicella-zoster virus RNA in human trigeminal ganglia. Lancet (1983) 2.39

Mr 26,000 antigen of Schistosoma japonicum recognized by resistant WEHI 129/J mice is a parasite glutathione S-transferase. Proc Natl Acad Sci U S A (1986) 2.35

Location and orientation of homologous sequences in the genomes of five herpesviruses. J Gen Virol (1983) 2.29

Regulation of varicella-zoster virus gene expression in human T lymphocytes. J Virol (1992) 2.12

Varicella-zoster virus open reading frame 61 protein is functionally homologous to herpes simplex virus type 1 ICP0. J Virol (1992) 2.09

The regulation of transcription of viral and cellular genes by herpesvirus immediate-early gene products (review). Anticancer Res (1987) 1.92

Interaction with nucleic acids and stimulation of the viral DNA polymerase by the herpes simplex virus type 1 major DNA-binding protein. J Virol (1984) 1.91

Cell lines containing varicella-zoster virus open reading frame 62 and expressing the "IE" 175 protein complement ICP4 mutants of herpes simplex virus type 1. J Virol (1988) 1.78

Characterization of regulatory functions of the varicella-zoster virus gene 63-encoded protein. J Virol (1992) 1.68

Varicella-zoster virus complements herpes simplex virus type 1 temperature-sensitive mutants. J Virol (1987) 1.64

Characterization of a potent varicella-zoster virus-encoded trans-repressor. J Virol (1991) 1.57

Varicella-zoster virus open reading frame 4 protein is functionally distinct from and does not complement its herpes simplex virus type 1 homolog, ICP27. J Virol (1994) 1.52

Differential regulation by varicella-zoster virus (VZV) and herpes simplex virus type-1 trans-activating genes. Virology (1989) 1.47

The product of varicella-zoster virus gene 62 autoregulates its own promoter. J Gen Virol (1990) 1.43

The immediate early proteins of varicella-zoster virus. Virology (1987) 1.39

Characterization of the regulatory functions of varicella-zoster virus open reading frame 4 gene product. J Virol (1993) 1.30

An in vivo model of varicella-zoster virus latent infection of dorsal root ganglia. J Neurosci Res (1990) 1.25

Monoclonal antibody to immediate early protein encoded by varicella-zoster virus gene 62. Virus Res (1990) 1.25

Molecular biology of varicella zoster virus. Adv Virus Res (1990) 1.15

Expression of varicella-zoster virus and herpes simplex virus in normal human trigeminal ganglia. Proc Natl Acad Sci U S A (1988) 1.14

Trans-activation of viral tk promoters by proteins encoded by varicella zoster virus open reading frames 61 and 62. Virus Res (1990) 1.07

Comparative immunohistochemical study of herpes simplex and varicella-zoster infections. Virchows Arch A Pathol Anat Histopathol (1993) 1.05

Varicella-zoster virus infection of adult rat sensory neurons in vitro. J Virol (1989) 1.02

Varicella-zoster virus (VZV)-specific polypeptides detected in cells treated with metabolic inhibitors. Microbiol Immunol (1985) 0.86

Recovery of cell-free varicella virus from Vero cells. Arch Virol (1981) 0.84

Articles by these authors

Varicella zoster virus, a cause of waxing and waning vasculitis: the New England Journal of Medicine case 5-1995 revisited. Neurology (1996) 4.02

Specific interaction of cellular factors with the B enhancer of polyoma virus. EMBO J (1985) 3.23

The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol Cell Biol (1994) 3.16

Two different factors bind to the alpha-domain of the polyoma virus enhancer, one of which also interacts with the SV40 and c-fos enhancers. EMBO J (1987) 3.09

Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons. Proc Natl Acad Sci U S A (1996) 2.71

TNF stimulates expression of mouse MHC class I genes by inducing an NF kappa B-like enhancer binding activity which displaces constitutive factors. EMBO J (1989) 2.65

Induction of a factor that binds to the polyoma virus A enhancer on differentiation of embryonal carcinoma cells. Nature (1987) 2.65

Quality of life in persons with human immunodeficiency virus infection: measurement by the Medical Outcomes Study instrument. Ann Intern Med (1992) 2.40

Activation of the polyomavirus enhancer by a murine activator protein 1 (AP1) homolog and two contiguous proteins. Proc Natl Acad Sci U S A (1988) 2.24

The mdm-2 gene is induced in response to UV light in a p53-dependent manner. Proc Natl Acad Sci U S A (1993) 2.01

DNA sequence of the carA gene and the control region of carAB: tandem promoters, respectively controlled by arginine and the pyrimidines, regulate the synthesis of carbamoyl-phosphate synthetase in Escherichia coli K-12. Proc Natl Acad Sci U S A (1984) 1.81

Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons. J Gen Intern Med (1991) 1.80

IS3 can function as a mobile promoter in E. coli. Nucleic Acids Res (1982) 1.75

Characterization of regulatory functions of the varicella-zoster virus gene 63-encoded protein. J Virol (1992) 1.68

The regulatory region of the divergent argECBH operon in Escherichia coli K-12. Nucleic Acids Res (1982) 1.60

Reactive oxygen intermediate-dependent NF-kappaB activation by interleukin-1beta requires 5-lipoxygenase or NADPH oxidase activity. Mol Cell Biol (1999) 1.57

PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress. Cell Death Differ (2012) 1.57

Variation in health service use among HIV-infected patients. Med Care (1992) 1.56

Molecular basis for modulated regulation of gene expression in the arginine regulon of Escherichia coli K-12. Nucleic Acids Res (1983) 1.49

Varicella-Zoster virus gene expression in latently infected rat dorsal root ganglia. Virology (2001) 1.45

Homologous control sites and DNA transcription starts in the related argF and argI genes of Escherichia coli K12. EMBO J (1982) 1.43

Evolutionary divergence of genes for ornithine and aspartate carbamoyl-transferases--complete sequence and mode of regulation of the Escherichia coli argF gene; comparison of argF with argI and pyrB. Nucleic Acids Res (1984) 1.37

Crucial role of the amino-terminal tyrosine residue 42 and the carboxyl-terminal PEST domain of I kappa B alpha in NF-kappa B activation by an oxidative stress. J Immunol (2000) 1.33

Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC). Clin Infect Dis (1994) 1.32

Intracellular transport of the glycoproteins gE and gI of the varicella-zoster virus. gE accelerates the maturation of gI and determines its accumulation in the trans-Golgi network. J Biol Chem (1998) 1.31

Characterization of the regulatory functions of varicella-zoster virus open reading frame 4 gene product. J Virol (1993) 1.30

Efficient formation of a crosslinkable HMT monoadduct at the Kpn I recognition site. Photochem Photobiol (1984) 1.30

Fibronectin promotes rat Schwann cell growth and motility. J Cell Biol (1982) 1.29

Protein-binding elements in the promoter region of the mouse p53 gene. Oncogene (1990) 1.27

Vimentin expression in cervical carcinomas: association with invasive and migratory potential. J Pathol (1996) 1.27

Oxidative stress interference with the nuclear factor-kappa B activation pathways. Biochem Pharmacol (2000) 1.25

An in vivo model of varicella-zoster virus latent infection of dorsal root ganglia. J Neurosci Res (1990) 1.25

MDM2: life without p53. Trends Genet (2001) 1.22

Communication of preferences for care among human immunodeficiency virus-infected patients. Barriers to informed decisions? Arch Fam Med (1997) 1.21

Molecular analysis of the interaction between an enhancer binding factor and its DNA target. Nucleic Acids Res (1986) 1.19

Varicella-zoster virus induces apoptosis in cell culture. J Gen Virol (1995) 1.15

The ATM protein is required for sustained activation of NF-kappaB following DNA damage. Oncogene (1999) 1.14

Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells. Oncogene (2007) 1.14

Anti-apoptotic activity of low levels of wild-type p53. EMBO J (1996) 1.13

Varicella-zoster virus latency in the adult rat is a useful model for human latent infection. Neurology (1995) 1.13

Assessment of pain in herpes zoster: lessons learned from antiviral trials. Antiviral Res (1997) 1.12

Singlet oxygen-induced mutations in M13 lacZ phage DNA. EMBO J (1987) 1.12

High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int J Cancer (1996) 1.11

Perceived need for dental care among persons living with acquired immunodeficiency syndrome. Med Care (1991) 1.11

Muscle-specific expression of the acetylcholine receptor alpha-subunit gene requires both positive and negative interactions between myogenic factors, Sp1 and GBF factors. EMBO J (1993) 1.10

Influence of innervation of myogenic factors and acetylcholine receptor alpha-subunit mRNAs. Neuroreport (1991) 1.08

Varicella-zoster virus open reading frame 4 encodes an immediate-early protein with posttranscriptional regulatory properties. J Virol (1997) 1.07

Mutagenesis of the lac promoter region in M13 mp10 phage DNA by 4'-hydroxymethyl-4,5',8-trimethylpsoralen. Proc Natl Acad Sci U S A (1985) 1.07

Regulation of interleukin-6 gene expression by pro-inflammatory cytokines in a colon cancer cell line. Biochem J (2000) 1.05

Comparative immunohistochemical study of herpes simplex and varicella-zoster infections. Virchows Arch A Pathol Anat Histopathol (1993) 1.05

Distinct signal transduction pathways mediate nuclear factor-kappaB induction by IL-1beta in epithelial and lymphoid cells. J Immunol (1997) 1.03

Varicella-zoster virus infection of adult rat sensory neurons in vitro. J Virol (1989) 1.02

Transcriptional mapping of the varicella-zoster virus regulatory genes encoding open reading frames 4 and 63. J Virol (1994) 1.02

Cell type-specific role for reactive oxygen species in nuclear factor-kappaB activation by interleukin-1. Biochem Pharmacol (2000) 1.01

A new topical treatment for resistant herpes simplex infections. N Engl J Med (1993) 1.01

Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines. Oncol Res (1998) 1.00

Nuclear factor-kappaB activation by the photochemotherapeutic agent verteporfin. Blood (2000) 0.99

Community-based case management for persons with AIDS. Health Aff (Millwood) (1989) 0.99

Stimulation of glutathione peroxidase activity decreases HIV type 1 activation after oxidative stress. AIDS Res Hum Retroviruses (1994) 0.98

Characterisation of membrane oligonucleotide-binding proteins and oligonucleotide uptake in keratinocytes. Nucleic Acids Res (1999) 0.98

The acidic amino-terminal region of varicella-zoster virus open reading frame 4 protein is required for transactivation and can functionally replace the corresponding region of herpes simplex virus ICP27. Virology (1995) 0.98

Skin color is relevant to vitamin D synthesis. Dermatology (2013) 0.98

Importance of post-transcriptional regulation of chemokine genes by oxidative stress. Biochem J (2001) 0.98

Mechanism of colon cancer cell apoptosis mediated by pyropheophorbide-a methylester photosensitization. Oncogene (2001) 0.98

Activation of human immunodeficiency virus type 1 by oxidative stress. AIDS Res Hum Retroviruses (1990) 0.97

Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional. Oncogene (2011) 0.97

Purification of circular DNA using benzoylated naphthoylated DEAE-cellulose. DNA (1985) 0.97

Non-enzymatic triggering of the ceramide signalling cascade by solar UVA radiation. EMBO J (2000) 0.96

Mutational analysis of varicella-zoster virus major immediate-early protein IE62. Nucleic Acids Res (1995) 0.96

Switch from p53 to MDM2 as differentiating human keratinocytes lose their proliferative potential and increase in cellular size. Oncogene (2000) 0.95

Topoisomerase poisons activate the transcription factor NF-kappaB in ACH-2 and CEM cells. Nucleic Acids Res (1996) 0.95

Varicella-zoster virus IE63, a virion component expressed during latency and acute infection, elicits humoral and cellular immunity. J Infect Dis (1998) 0.95

Molecular interactions in the control region of the carAB operon encoding Escherichia coli carbamoylphosphate synthetase. J Mol Biol (1988) 0.94

Physical symptoms and depressive symptoms among individuals with HIV infection. Psychosomatics (1992) 0.94

In vivo and in vitro analysis of electrical activity-dependent expression of muscle acetylcholine receptor genes using adenovirus. Proc Natl Acad Sci U S A (1994) 0.93

DNA synthesis on phi X174 template damaged by proflavine and light treatment. Photochem Photobiol (1982) 0.93

Meningoradiculoneuritis due to acyclovir-resistant varicella zoster virus in an acquired immune deficiency syndrome patient. J Med Virol (1994) 0.93

Iron chelation decreases NF-kappa B and HIV type 1 activation due to oxidative stress. AIDS Res Hum Retroviruses (1995) 0.92

Novel evidences for a tumor suppressor role of Rev3, the catalytic subunit of Pol zeta. Oncogene (2008) 0.92

Activation of the NF-kappaB transcription factor in a T-lymphocytic cell line by hypochlorous acid. Biochem J (1997) 0.92

Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes. J Immunol (1997) 0.92

Gene activation by Varicella-zoster virus IE4 protein requires its dimerization and involves both the arginine-rich sequence, the central part, and the carboxyl-terminal cysteine-rich region. J Biol Chem (2000) 0.92

The potential place of chloroquine in the treatment of HIV-1-infected patients. J Clin Virol (2001) 0.91

Restoration of SHIP-1 activity in human leukemic cells modifies NF-kappaB activation pathway and cellular survival upon oxidative stress. Oncogene (2006) 0.91